STAAR Surgical shares jumped 18% in after‑hours trading after reporting preliminary Q1 net sales above $90 million, beating $67.2 million estimate.
Q1 sales more than doubled year‑on‑year to $42.6 million in 2025, driven by strong demand in China and double‑digit growth in the Americas.
Middle East, parts of EMEA and APAC saw sales declines due to geopolitical challenges, which could continue to weigh on growth.